Herter-Sprie, Grit S.
Korideck, Houari
Christensen, Camilla L.
Herter, Jan M.
Rhee, Kevin
Berbeco, Ross I.
Bennett, David G.
Akbay, Esra A.
Kozono, David
Mak, Raymond H.
Mike Makrigiorgos, G.
Kimmelman, Alec C.
Wong, Kwok-Kin
Article History
Received: 11 July 2014
Accepted: 14 November 2014
First Online: 18 December 2014
Competing interests
: R.H.M. served as a consultant to Boehringer Ingelheim. A.C.K. serves as a consultant to Forma Therapeutics. K.-K.W. owns equity in and receives compensation from G1 Therapeutics, serves as a consultant to MolecularMD and has sponsored research agreements with AstraZeneca, Gilead, Takeda and Millennium Pharmaceuticals. The remaining authors declare no competing financial interest.